99 related articles for article (PubMed ID: 23455779)
1. Relation of CD117 immunoreactivity and microvascular density in invasive breast carcinoma.
Amin MM; El-Hawary AK; Farouk O
Indian J Pathol Microbiol; 2012; 55(4):456-60. PubMed ID: 23455779
[TBL] [Abstract][Full Text] [Related]
2. CD34, CD117, and actin expression in phyllodes tumor of the breast.
Chen CM; Chen CJ; Chang CL; Shyu JS; Hsieh HF; Harn HJ
J Surg Res; 2000 Dec; 94(2):84-91. PubMed ID: 11104647
[TBL] [Abstract][Full Text] [Related]
3. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
4. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
[TBL] [Abstract][Full Text] [Related]
5. CD117 and CD34 staining patterns in childhood benign mammary lesions.
Kaçar A; Paker I; Akbiyik F; Arikök AT; Mambet E
Turk Patoloji Derg; 2012; 28(1):31-7. PubMed ID: 22207429
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of D2-40 and CD34 in invasive ductal carcinoma of the breast and the clinical implications].
Zhen LF; Ye CS; Liu MF; Ding GP; Liao JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1548-51. PubMed ID: 20650763
[TBL] [Abstract][Full Text] [Related]
7. Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.
Mylona E; Magkou C; Giannopoulou I; Agrogiannis G; Markaki S; Keramopoulos A; Nakopoulou L
Breast Cancer Res; 2006; 8(5):R57. PubMed ID: 17032447
[TBL] [Abstract][Full Text] [Related]
8. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.
Şener E; Şipal S; Gündoğdu C
Turk Patoloji Derg; 2016; 32(3):164-70. PubMed ID: 27562390
[TBL] [Abstract][Full Text] [Related]
10. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
Nassar A; Sussman ZM; Lawson D; Cohen C
Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
[TBL] [Abstract][Full Text] [Related]
11. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
Jang KS; Han HX; Paik SS; Brown PH; Kong G
Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
[TBL] [Abstract][Full Text] [Related]
12. Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients.
Florena AM; Tripodo C; Guarnotta C; Ingrao S; Porcasi R; Martorana A; Lo Bosco G; Cabibi D; Franco V
Pathobiology; 2007; 74(6):317-22. PubMed ID: 18087195
[TBL] [Abstract][Full Text] [Related]
13. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S
Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784
[TBL] [Abstract][Full Text] [Related]
15. A distinct microvascular pattern accompanied by aggressive clinical course in breast carcinomas: a fact or a coincidence?
Safali M; Karslioğlu Y; Arpaci F; Kurt B; Günhan O
Pathol Res Pract; 2010 Feb; 206(2):93-7. PubMed ID: 19945801
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of microvessel density in breast cancer of Thai women.
Kanjanapanjapol S; Wongwaisayawan S; Phuwapraisirisan S; Wilasrusmee C
J Med Assoc Thai; 2007 Feb; 90(2):282-90. PubMed ID: 17375633
[TBL] [Abstract][Full Text] [Related]
17. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
[TBL] [Abstract][Full Text] [Related]
19. Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.
Ayadi L; Khabir A; Amouri H; Karray S; Dammak A; Guermazi M; Boudawara T
World J Surg Oncol; 2008 Oct; 6():112. PubMed ID: 18945339
[TBL] [Abstract][Full Text] [Related]
20. [Focal adhesion kinase expression and angiogenesis in breast carcinoma].
Huang YD; Zhang S
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1370-3. PubMed ID: 17884781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
